+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Regulatory Affairs"

Process Validation - Overview of Why and How - Webinar (Recorded) - Product Thumbnail Image

Process Validation - Overview of Why and How - Webinar (Recorded)

  • Webinar
  • August 2019
  • 90 Minutes
  • Global
Raw Materials in Pharma/Biotech Production - Webinar (Recorded) - Product Thumbnail Image

Raw Materials in Pharma/Biotech Production - Webinar (Recorded)

  • Webinar
  • June 2019
  • 90 Minutes
  • Global
505(b)(2) NDAs - Webinar (Recorded) - Product Thumbnail Image

505(b)(2) NDAs - Webinar (Recorded)

  • Webinar
  • March 2019
  • 120 Minutes
  • Global
Meet the Tougher U.S. FDA CGMPs - Webinar (Recorded) - Product Thumbnail Image

Meet the Tougher U.S. FDA CGMPs - Webinar (Recorded)

  • Webinar
  • November 2018
  • 90 Minutes
  • United States
Loading Indicator

Regulatory Affairs in the biotechnology industry is the process of obtaining and maintaining approval from regulatory authorities for the development, manufacture, and marketing of biotechnology products. This includes the submission of applications, such as Investigational New Drug (IND) applications, New Drug Applications (NDAs), and Biologics License Applications (BLAs). Regulatory Affairs professionals are responsible for ensuring that biotechnology products comply with applicable laws and regulations. Regulatory Affairs professionals must have a thorough understanding of the regulatory environment and the ability to interpret and apply regulations to the development and marketing of biotechnology products. They must also be able to effectively communicate with regulatory authorities and other stakeholders. Companies in the Regulatory Affairs market in the biotechnology industry include Parexel, Quintiles, Covance, PRA Health Sciences, and Charles River Laboratories. Show Less Read more